SOMESThesia and ALIMentation (SOMEST'ALIM)

September 2, 2025 updated by: Hospices Civils de Lyon

SOMESThesia in Patients With Head and Neck Cancer: Variability and Influence on the ALIMentation Experience

Cancer patients are at high risk for undernutrition. A study with head and neck cancer patients showed that 50% suffered from undernutrition (Prevost et al., 2014). Sensory alterations may also involve sensory changes from the physiological structures of the mouth or neural pathways and hedonic changes, i.e., although food may taste the same as usual, that taste is no longer judged as pleasant. These changes lead to an aversion to food and a decrease in the pleasure of eating (Bernhardson et al., 2009).

Despite the large number of published studies on taste and smell alterations in diverse cancer populations, few have examined other dimensions of oral sensory alterations. Studies focusing on somesthesia have mostly been conducted in the area of oral physiology or stomatology in relation to oral pain and rehabilitation (Howes, Wongsriruksa, Laughlin, Witchel, & Miodownik, 2014).

Regarding food perception, somesthesia provides information about both texture, temperature, and trigeminal sensations. These sensations are detected by mechanical, thermal, nociceptive receptors present throughout the oral epithelium (Simons & Carstens, 2008). In addition to taste and smell, food perception is influenced by oral somatosensation and studies have demonstrated an interrelated relationship between these oral sensations (Spence, Piqueras-Fiszman 2016). Therefore, ther might have a correlation between oral somatosensation and food preferences, subsequently influencing eating behavior and food consumption. A standard method, using a so-called Von Frey Hair monofilament, to assess tactile sensation was developed by Etter et al. (Etter, N. M et al.,. J. Vis. Exp. 2020) but has so far been only minimally used in Ear, Nose and Throat (ENT) cancer (Bearelly, Wang, & Cheung, 2017; Bodin, Jäghagen, & Isberg, 2004; Elfring, Boliek, Seikaly, Harris, & Rieger, 2012).

The aim of the study is to determine the variability and role of somatosensory perception (texture, pungency transmitted through the trigeminal system, and temperature) on food preferences in cancer patients compared to healthy volunteers.

Study Overview

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lyon, France, 69004
        • Service d'Oncologie médicale, Hôpital de la Croix-Rousse
      • Écully, France, 69131
        • Centre de recherche de l'Institut Paul Bocuse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

All subjects:

  • Person between 18 and 65 years
  • Person having given free, informed, express written consent
  • Person affiliated to a French social security system
  • Person with a body mass superior to 18 kg/m².
  • Person able to come once to the Institut Paul Bocuse

Patients with head and neck cancer with chemotherapy:

- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiochemotherapy or radiochemotherapy alone

Patients with head and neck cancer without chemotherapy:

- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiation therapy or radiation therapy alone

Healthy volunteers :

  • Volunteer who is +/- 5 years of age relative to the patient to whom they are matched.
  • Volunteer of the same sex as the patient to whom they are matched
  • Volunteer with the same smoking status as the patient to whom they are matched
  • Volunteer who has not had cancer within 5 years at the time of inclusion
  • Volunteer with no current treatment that may affect taste and smell perception

Exclusion Criteria:

All subjects:

  • Person with a known food allergy/intolerance (lactose or milk protein) or unable to consume dairy or solid products (e.g., chocolate milk pudding, chocolate jelly)
  • Person with a known allergy to chili (or capsaicin)
  • Person with diagnosed total ageusia
  • Person with diagnosed total anosmia
  • Person who has used artificial feeding within 2 months prior to inclusion.
  • Person who has lost more than 10% of baseline weight in the 2 months prior to inclusion
  • Person deprived of liberty or under guardianship or trusteeship.
  • Pregnant or breastfeeding woman
  • Person deprived of liberty by a judicial or administrative decision
  • Person under guardianship or protection of vulnerable adults
  • Person with trismus (reduced jaw opening or limited jaw range of motion)
  • A person who is unable to extend his or her tongue
  • Person who has had surgery on the mobile tongue and/or base of the tongue
  • Person unable to swallow soft foods
  • Person who has had or is suspected of having had Corona Virus Disease (COVID)-19 within the last 6 months.

Patients with head and neck cancer:

  • Patient receiving immunotherapy
  • Patient treated with surgery only.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: head and neck cancer patients with radiotherapy AND chemotherapy
patients included for a head and neck cancer and treated by radiotherapy (+/- surgery) + chemotherapy
Patients will be included in the study between 3 to 6 months after the end of treatment and go to the Paul Bocuse Research Institute to perform several sensorial tests. The same sensorial tests will be completed by healthy volunteers to compare.
Patients will be included in the study between 3 to 6 months after the end of treatment and go at Institut Paul Bocuse to complete food preferences questionnaires. The same questionnaires will be completed by healthy volunteers to compare.
Experimental: head and neck cancer patients with radiotherapy only
patients included for a head and neck cancer and treated by radiotherapy (+/- surgery) without chemotherapy
Patients will be included in the study between 3 to 6 months after the end of treatment and go to the Paul Bocuse Research Institute to perform several sensorial tests. The same sensorial tests will be completed by healthy volunteers to compare.
Patients will be included in the study between 3 to 6 months after the end of treatment and go at Institut Paul Bocuse to complete food preferences questionnaires. The same questionnaires will be completed by healthy volunteers to compare.
Active Comparator: healthy volunteers
healthy volunteers paired with experimental patients on age (+/- 5 years), gender, tobacco status
Patients will be included in the study between 3 to 6 months after the end of treatment and go to the Paul Bocuse Research Institute to perform several sensorial tests. The same sensorial tests will be completed by healthy volunteers to compare.
Patients will be included in the study between 3 to 6 months after the end of treatment and go at Institut Paul Bocuse to complete food preferences questionnaires. The same questionnaires will be completed by healthy volunteers to compare.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral tactile sensitivity score
Time Frame: Up to 3 months after recruitment.
The primary endpoint of the study is to measure oral tactile sensitivity using the Von Frey Hair monofilament pressure test in head and neck cancer patients compared to healthy volunteers. This will be assessed at recruitment for healthy volunteers and between 1 to 3 months after recruitment for head and neck cancer patients.
Up to 3 months after recruitment.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
thermic sensitivity score
Time Frame: Up to 3 months after recruitment.
Measurement on a visual analog scale (gLMS) of sensitivity to heat and cold using dental mirrors. This will be assessed at recruitment for healthy volunteers and between 1 to 3 months after recruitment for head and neck cancer patients.
Up to 3 months after recruitment.
trigeminal sensitivity score
Time Frame: Up to 3 months after inclusion.
Visual analog scale (gLMS) measurement of trigeminal sensitivity using prepared solutions. This will be assessed at inclusion for healthy volunteers and between 1 to 3 months after inclusion for head and neck cancer patients.
Up to 3 months after inclusion.
texture sensitivity score
Time Frame: Up to 3 months after recruitment.
Measurement of texture sensitivity (firmness, consistency, and roughness) on a visual analog scale (gLMS) from food samples. This will be assessed at recruitment for healthy volunteers and between 1 to 3 months after recruitment for head and neck cancer patients.
Up to 3 months after recruitment.
salivary function
Time Frame: Up to 3 months after recruitment.
Saliva function measurement with a BUFFER Saliva-check kit. This will be assessed at recruitment for healthy volunteers and between 1 to 3 months after recruitment for head and neck cancer patients.
Up to 3 months after recruitment.
food preference score
Time Frame: Up to 3 months after recruitment.
Measurement of food preference based on food pictures on a visual analog scale and according to the participant's ethnicity, family and social status. This will be assessed at recruitment for healthy volunteers and between 1 to 3 months after recruitment for head and neck cancer patients.
Up to 3 months after recruitment.
sensory perception, dietary habits and oral health
Time Frame: Up to 3 months after recruitment.
Measured by self-reported questionnaires of subjective sensory perception, dietary habits, and oral health and according to the participant's ethnicity, family and social status. This will be assessed at recruitment for healthy volunteers and between 1 to 3 months after recruitment for head and neck cancer patients.
Up to 3 months after recruitment.
correlation sensory perception and food preferences
Time Frame: Up to 3 months after recruitment.
Correlation analysis between sensory perception and food preferences for each participant. This will be assessed at recruitment for healthy volunteers and between 1 to 3 months after recruitment for head and neck cancer patients.
Up to 3 months after recruitment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amandine BRUYAS, Hospices Civils de Lyon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2022

Primary Completion (Actual)

April 14, 2023

Study Completion (Actual)

April 14, 2023

Study Registration Dates

First Submitted

February 14, 2022

First Submitted That Met QC Criteria

March 8, 2022

First Posted (Actual)

March 10, 2022

Study Record Updates

Last Update Posted (Estimated)

September 9, 2025

Last Update Submitted That Met QC Criteria

September 2, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 69HCL21_1153

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Head and Neck Cancers

Clinical Trials on Sensorial tests

Subscribe